COMMUNIQUÉS West-GlobeNewswire

-
Principia Achieves $10 Million in Additional Milestones Related to Development of PRN2246/SAR442168
16/10/2018 -
Cancer Genetics Issues Letter to Shareholders
16/10/2018 -
Medovex Corporation Announces Definitive Agreement to Acquire the Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
16/10/2018 -
Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of XERMELO® (Telotristat Ethyl) for the Treatment of Refractory Carcinoid Syndrome Diarrhea in Combination With Somatostatin Analog Therapy
16/10/2018 -
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
16/10/2018 -
AzurRx BioPharma Announces FDA Acceptance of IND Application for Phase 2 Clinical Trial of MS1819-SD in Patients with Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
16/10/2018 -
Cytokinetics Unveils Expanded Development Pipeline and Provides Key Updates on Late-Stage Clinical Research Programs at R&D Day
16/10/2018 -
Stemline Therapeutics Announces SL-701 and SL-801 Clinical Data to be Featured, Including an Oral Presentation, at Upcoming ESMO 2018 Congress
16/10/2018 -
resTORbio Announces Additional RTB101 Phase 2b Data Demonstrating Decreased Incidence of Laboratory-Confirmed RTIs with Severe Symptoms, Total Infections and UTIs
16/10/2018 -
BeyondSpring’s Lead Asset, Plinabulin, Prevents Docetaxel Chemo-Induced-Neutropenia (CIN) Due to a Mechanism of Action Differentiated from G-CSF
16/10/2018 -
Axsome Therapeutics to Host Call Today with Key Opinion Leader Focusing on AXS-12 and Unmet Needs in Narcolepsy
16/10/2018 -
Reata Announces Presentation of Four Clinical Abstracts at the American Society of Nephrology Kidney Week 2018
16/10/2018 -
Voyager Therapeutics Announces Preclinical Data for Huntington’s Disease and Amyotrophic Lateral Sclerosis Programs at the Congress of the European Society of Gene and Cell Therapy
16/10/2018 -
AxoGen, Inc. to Report Third Quarter 2018 Financial Results and Host Conference Call on October 29, 2018
16/10/2018 -
U.S. FDA Approves Cost Recovery for PLX-PAD under Expanded Access Program in the Treatment of Critical Limb Ischemia
16/10/2018 -
Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil
16/10/2018 -
Axsome Therapeutics Announces AXS-12 for the Treatment of Narcolepsy
16/10/2018 -
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
16/10/2018 -
ImprimisRx to feature new formulation and poster presentation on MKO Melt® at the upcoming American Academy of Ophthalmology Meeting in Chicago
16/10/2018
Pages